Literature DB >> 18789552

Uniformity in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes.

Akihisa Imagawa1, Toshiaki Hanafusa, Hiromi Iwahashi, Yasuko Uchigata, Azuma Kanatsuka, Eiji Kawasaki, Tetsuro Kobayashi, Akira Shimada, Ikki Shimizu, Taro Maruyama, Hideichi Makino.   

Abstract

To clarify the detailed clinical features and HLA subtype in the patients with fulminant type 1 diabetes, we investigated consecutive 250 case records registered to the committee of the Japan Diabetes Society between 2000/7/15 and 2006/6/30. After the classification with age at onset or gender, clinical data and HLA DR were evaluated. As a result, the prevalence of male patients, BMI, HbA(1c) and ALT levels at the onset increased significantly according to the elder quartile, but no other data showed any significant difference. Only age at onset and blood glucose level were significantly higher in male patients than in female patients without pregnancy by multivariate analysis. The distribution of HLA DR was not different in any subtype by gender or age at onset. Our present study revealed common feature in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes except pregnant women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789552     DOI: 10.1016/j.diabres.2008.08.003

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Fulminant type 1 diabetes as an important exception to the new diagnostic criteria using HbA(1c)--response to the International Expert Committee.

Authors:  A Imagawa; T Hanafusa
Journal:  Diabetologia       Date:  2009-09-01       Impact factor: 10.122

2.  Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012).

Authors:  Akihisa Imagawa; Toshiaki Hanafusa; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Haruhiko Osawa; Eiji Kawasaki; Yumiko Kawabata; Tetsuro Kobayashi; Akira Shimada; Ikki Shimizu; Kazuma Takahashi; Masao Nagata; Hideichi Makino; Taro Maruyama
Journal:  J Diabetes Investig       Date:  2012-11-30       Impact factor: 4.232

3.  Epidemiology and phenotypes of diabetes in children and adolescents in non-European-origin populations in or from Western Pacific region.

Authors:  Steven James; Jayanthi Maniam; Pik-To Cheung; Tatsuhiko Urakami; Julia von Oettingen; Supawadee Likitmaskul; Graham Ogle
Journal:  World J Clin Pediatr       Date:  2022-03-09

4.  Fulminant Type 1 Diabetes Mellitus Associated With Drug Hypersensitivity and Epstein-Barr Virus Infection: A Case Report.

Authors:  Xing-Yu Chen; Cong Wang; Shizhi Chen; Mingyuan Tian; Xin Wang; Lili Zhang
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

5.  Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy.

Authors:  Megu Yamaguchi Baden; Akihisa Imagawa; Norio Abiru; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Yoichi Oikawa; Haruhiko Osawa; Hiroshi Kajio; Eiji Kawasaki; Yumiko Kawabata; Junji Kozawa; Akira Shimada; Kazuma Takahashi; Shoichiro Tanaka; Daisuke Chujo; Tomoyasu Fukui; Junnosuke Miura; Kazuki Yasuda; Hisafumi Yasuda; Tetsuro Kobayashi; Toshiaki Hanafusa
Journal:  Diabetol Int       Date:  2018-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.